RIPK1 is not essential for TNFR1-induced activation of NF-kappa B

WW-L Wong; IE Gentle; U Nachbur; H Anderton; DL Vaux; J Silke

Journal article

RIPK1 is not essential for TNFR1-induced activation of NF-kappa B

WW-L Wong, IE Gentle, U Nachbur, H Anderton, DL Vaux, J Silke

Cell Death Differ. | NATURE PUBLISHING GROUP | Published : 2010

DOI: 10.1038/cdd.2009.178

University of Melbourne Researchers

David Vaux Author Medical Biology (W.E.H.I.)

Ulrich Nachbur Author Medical Biology (W.E.H.I.)

John Silke Author Medical Biology (W.E.H.I.)

Grants

Awarded by NHMRC

Awarded by Leukemia and Lymphoma Society

Funding Acknowledgements

We thank Michelle Kelliher for providing RIPK1-/- mice; Heinrich Korner for providing TNFR1-/- and TNFR2-/- mice; M McKinlay for supplying IAP antagonist, comp A (TetraLogic Pharmaceuticals); JE Vince for critical reading of the paper. JS is funded by the NHMRC (433013, 541901 and 541902). DLV is an NHMRC Australian Fellow, funded by the Leukemia and Lymphoma Society and the NHMRC (461221). IEG is funded by NHMRC Australian Postdoctoral Training Fellowship (487348). UN is funded by Swiss National Science Foundation.